Wenfang Bi

462 citations
7 papers · 327 indexed · h-index 6
Topics
Carcinogens and Genotoxicity Assessment (4 papers)Epigenetics and DNA Methylation (3 papers)RNA modifications and cancer (2 papers)

In The Last Decade

Wenfang Bi

7 papers receiving 313 citations

Peers

Wenfang Bi
Comparison fields: 5 of 72
  • Molecular Biology 166
  • Cancer Research 127
  • Oncology 73
  • Surgery 66
  • Health, Toxicology and Mutagenesis 44
Replace Carl R. Morris with:
Carl R. Morris United States
Masae Tatematsu Japan
S. Anttila Finland
Hijiri Takeuchi Japan
M Reinikainen Finland
Geoff Margison United Kingdom
Carol Jones United States
N. Caporaso United States
Ruth E. Gibson‐D'Ambrosio United States
Jason Neale United States
Wenfang Bi relative to Carl R. Morris United States Carl R. Morris's profile →
Citations per field
00.5×
Carl R. Morris · 1×
Citations per year

Countries citing papers authored by Wenfang Bi

Since Specialization
Citations

This map shows the geographic impact of Wenfang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfang Bi more than expected).

Fields of papers citing papers by Wenfang Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfang Bi. The network helps show where Wenfang Bi may publish in the future.

Co-authorship network of co-authors of Wenfang Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfang Bi. A scholar is included among the top collaborators of Wenfang Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfang Bi. Wenfang Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 57
2
No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
47
3
Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
5
4 44
5 94
6 62
7 18

About Wenfang Bi

Wenfang Bi is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 7 papers that have together received 327 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (127 citations), Chemical Health and Safety (4 citations) and Pharmacology (34 citations). Wenfang Bi has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Richard B. Hayes, Nathaniel Rothman, Songnian Yin, Neil E. Caporaso, Urs Meyer, Raymond L. Woosley, Franck Broly, Ya Cao, W. J. Blot and Z. Ma. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Carcinogenesis and Ecotoxicology and Environmental Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026